Midwest Eye Institute - North

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Diabetic eye disease
• Macular degeneration

Running trials

• Active, not recruiting

  Safety, Tolerability and PK of Subcutaneous D-4517.2 in Subjects With Wet AMD or DME

  NCT05387837· Phase 2· Ashvattha Therapeutics, Inc.· Source